Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cal-1 gene therapy in HIV-related lymphoma
NCT03593187Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2019
- Primary completion
- Jul 2020
- Modality
- Gene Editing, Gene Silencing, RNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Cal-1 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2019; status: completed.
02
Drugs
Cal-1
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03593187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593187.